Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 211

1.

Effect of aspirin on mortality in the primary prevention of cardiovascular disease.

Raju N, Sobieraj-Teague M, Hirsh J, O'Donnell M, Eikelboom J.

Am J Med. 2011 Jul;124(7):621-9. doi: 10.1016/j.amjmed.2011.01.018. Epub 2011 May 17.

PMID:
21592450
[PubMed - indexed for MEDLINE]
2.

Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.

Sutcliffe P, Connock M, Gurung T, Freeman K, Johnson S, Kandala NB, Grove A, Gurung B, Morrow S, Clarke A.

Health Technol Assess. 2013 Sep;17(43):1-253. doi: 10.3310/hta17430. Review.

PMID:
24074752
[PubMed - indexed for MEDLINE]
Free Article
3.

Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis.

Butalia S, Leung AA, Ghali WA, Rabi DM.

Cardiovasc Diabetol. 2011 Apr 1;10:25. doi: 10.1186/1475-2840-10-25. Review.

PMID:
21453547
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Validity of composite outcomes in meta-analyses of stroke prevention trials: the case of aspirin.

McGrath E, O'Conghaile A, Eikelboom JW, Dinneen SF, Oczkowski C, O'Donnell MJ.

Cerebrovasc Dis. 2011;32(1):22-7. doi: 10.1159/000324629. Epub 2011 May 11.

PMID:
21576939
[PubMed - indexed for MEDLINE]
5.

Antiplatelet agents for intermittent claudication.

Wong PF, Chong LY, Mikhailidis DP, Robless P, Stansby G.

Cochrane Database Syst Rev. 2011 Nov 9;(11):CD001272. doi: 10.1002/14651858.CD001272.pub2. Review.

PMID:
22071801
[PubMed - indexed for MEDLINE]
6.

Antiplatelet agents for chronic kidney disease.

Palmer SC, Di Micco L, Razavian M, Craig JC, Perkovic V, Pellegrini F, Jardine MJ, Webster AC, Zoungas S, Strippoli GF.

Cochrane Database Syst Rev. 2013 Feb 28;2:CD008834. doi: 10.1002/14651858.CD008834.pub2. Review.

PMID:
23450589
[PubMed - indexed for MEDLINE]
7.

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.

Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, Hennekens CH, Buring JE.

N Engl J Med. 2005 Mar 31;352(13):1293-304. Epub 2005 Mar 7.

PMID:
15753114
[PubMed - indexed for MEDLINE]
Free Article
8.

Systematic reporting bias in meta-analyses of trials of aspirin for the primary prevention of cardiovascular disease.

Cleland JG.

Am J Med. 2012 Feb;125(2):e13. doi: 10.1016/j.amjmed.2011.08.027. No abstract available.

PMID:
22269629
[PubMed - indexed for MEDLINE]
9.

Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials.

De Berardis G, Sacco M, Strippoli GF, Pellegrini F, Graziano G, Tognoni G, Nicolucci A.

BMJ. 2009 Nov 6;339:b4531. doi: 10.1136/bmj.b4531. Review. Erratum in: BMJ. 2010;340:c374.

PMID:
19897665
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials.

Sanmuganathan PS, Ghahramani P, Jackson PR, Wallis EJ, Ramsay LE.

Heart. 2001 Mar;85(3):265-71.

PMID:
11179262
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials.

Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL.

JAMA. 2006 Jan 18;295(3):306-13. Erratum in: JAMA. 2006 May 3;295(17):2002.

PMID:
16418466
[PubMed - indexed for MEDLINE]
12.

Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force.

Wolff T, Miller T, Ko S.

Ann Intern Med. 2009 Mar 17;150(6):405-10. Review.

PMID:
19293073
[PubMed - indexed for MEDLINE]
13.

Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force.

Hayden M, Pignone M, Phillips C, Mulrow C.

Ann Intern Med. 2002 Jan 15;136(2):161-72.

PMID:
11790072
[PubMed - indexed for MEDLINE]
14.

Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials.

Leonardi-Bee J, Bath PM, Bousser MG, Davalos A, Diener HC, Guiraud-Chaumeil B, Sivenius J, Yatsu F, Dewey ME; Dipyridamole in Stroke Collaboration (DISC).

Stroke. 2005 Jan;36(1):162-8. Epub 2004 Nov 29. Review.

PMID:
15569877
[PubMed - indexed for MEDLINE]
Free Article
15.

Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.

Vrecer M, Turk S, Drinovec J, Mrhar A.

Int J Clin Pharmacol Ther. 2003 Dec;41(12):567-77.

PMID:
14692706
[PubMed - indexed for MEDLINE]
16.

Incremental effect of clopidogrel on important outcomes in patients with cardiovascular disease: a meta-analysis of randomized trials.

Helton TJ, Bavry AA, Kumbhani DJ, Duggal S, Roukoz H, Bhatt DL.

Am J Cardiovasc Drugs. 2007;7(4):289-97.

PMID:
17696569
[PubMed - indexed for MEDLINE]
17.

Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis.

Fretheim A, Odgaard-Jensen J, Brørs O, Madsen S, Njølstad I, Norheim OF, Svilaas A, Kristiansen IS, Thürmer H, Flottorp S.

BMC Med. 2012 Apr 5;10:33. doi: 10.1186/1741-7015-10-33. Review.

PMID:
22480336
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

The role of aspirin in primary prevention of vascular events.

Badri M, Saeed W, Sardar MR.

Am J Med. 2012 Dec;125(12):e11. doi: 10.1016/j.amjmed.2012.03.018. No abstract available.

PMID:
23164487
[PubMed - indexed for MEDLINE]
19.

Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis.

Zhang C, Sun A, Zhang P, Wu C, Zhang S, Fu M, Wang K, Zou Y, Ge J.

Diabetes Res Clin Pract. 2010 Feb;87(2):211-8. doi: 10.1016/j.diabres.2009.09.029. Epub 2009 Oct 23.

PMID:
19853947
[PubMed - indexed for MEDLINE]
20.

Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit.

Rothberg MB, Celestin C, Fiore LD, Lawler E, Cook JR.

Ann Intern Med. 2005 Aug 16;143(4):241-50.

PMID:
16103468
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk